• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,143
110
76
72
69

COUNTRY

71
22
16
10
9

CATEGORIES

  • 575
  • 121
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,047
1,293
2,049
3,059

PUBLISHED

79
253
695
3,059

PRODUCT TYPE

2,431
494
69
62
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Medulloblastoma Global Clinical Trials Review, H2, 2013

Medulloblastoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Medulloblastoma Global Clinical Trials Review, H2, 2013" provides data on the Medulloblastoma clinical trial...

December 2013
FROM

Mantle Cell Lymphoma Global Clinical Trials Review, H2, 2013

“Mantle Cell Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Mantle Cell Lymphoma clinical trial scenario This report provides elemental information and data relating to the clinical...

December 2013
FROM

Ependymoma Global Clinical Trials Review, H2, 2013

“Ependymoma Global Clinical Trials Review, H2, 2013" provides data on the Ependymoma clinical trial scenario This report provides elemental information and data relating to the clinical trials on Ependymoma...

December 2013
FROM

Global Gynecological Cancers Market 2014-2018

The analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase...

December 2013
FROM

Cell Press Reviews: Cancer Therapeutics. Cell Press Reviews Series

Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated...

December 2013

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth

Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract They are often diagnosed at advanced, incurable stages due to a late onset of symptoms, but are also associated with...

December 2013
FROM

Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth

There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix The current...

December 2013
FROM
Cancer Drug Design and Discovery. Edition No. 2 Cancer Drug Design and Discovery. Edition No. 2 - Product Thumbnail Image

Cancer Drug Design and Discovery. Edition No. 2

Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters...

December 2013
2014 World Tumor Markers Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers 2014 World Tumor Markers Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers - Product Thumbnail Image

2014 World Tumor Markers Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading...

December 2013
FROM
Physician Views: Bayer's M&A Catalyst – is Xofigo a Paradigm Shifter for the Prostate Cancer Market? Physician Views: Bayer's M&A Catalyst – is Xofigo a Paradigm Shifter for the Prostate Cancer Market? - Product Thumbnail Image

Physician Views: Bayer's M&A Catalyst – is Xofigo a Paradigm Shifter for the Prostate Cancer Market?

Already positioned as one of the most commercially promising new drug approvals of 2013, Algeta and Bayer's prostate cancer treatment Xofigo is now driving what appears to be the inevitable acquisition...

December 2013

Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013

Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Non-Hodgkin Lymphoma...

November 2013
FROM

Ovarian Cancer Global Clinical Trials Review, H2, 2013

Ovarian Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial...

November 2013
FROM

Endometrial Cancer Global Clinical Trials Review, H2, 2013

Endometrial Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2013" provides data on the Endometrial Cancer clinical...

November 2013
FROM

Rhabdomyosarcoma Global Clinical Trials Review, H2, 2013

Rhabdomyosarcoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Rhabdomyosarcoma clinical...

November 2013
FROM

Ewing Sarcoma Global Clinical Trials Review, H2, 2013

Ewing Sarcoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H2, 2013" provides data on the Ewing Sarcoma clinical trial scenario....

November 2013
FROM

Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2013

Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2013" provides data on the Hepatic (Liver)...

November 2013
FROM

Gastric Cancer Global Clinical Trials Review, H2, 2013

Gastric Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2013" provides data on the Gastric Cancer clinical trial...

November 2013
FROM

Cervical Cancer Global Clinical Trials Review, H2, 2013

Cervical Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2013" provides data on the Cervical Cancer clinical trial...

November 2013
FROM

Prostate Cancer Global Clinical Trials Review, H2, 2013

Prostate Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Prostate Cancer Global Clinical Trials Review, H2, 2013" provides data on the Prostate Cancer clinical trial...

November 2013
FROM

Laryngeal Cancer Global Clinical Trials Review, H2, 2013

Laryngeal Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Laryngeal Cancer clinical...

November 2013
FROM
Loading Indicator

Our Clients

Our clients' logos